Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin HIV AIDS. 2012 Nov;7(6):569-78. doi: 10.1097/COH.0b013e328358bac9.

Antiretrovirals and safer conception for HIV-serodiscordant couples.

Author information

1
Massachusetts General Hospital, Center for Global Health and Division of Infectious Disease, Boston, USA. ltmatthe@bidmc.harvard.edu

Erratum in

  • Curr Opin HIV AIDS. 2013 Jan;8(1):86.

Abstract

PURPOSE OF REVIEW:

Many men and women living with HIV and their uninfected partners attempt to conceive children. HIV-prevention science can be applied to reduce sexual transmission risk while respecting couples' reproductive goals. Here we discuss antiretrovirals as prevention in the context of safer conception for HIV-serodiscordant couples.

RECENT FINDINGS:

Antiretroviral therapy (ART) for the infected partner and pre-exposure prophylaxis (PrEP) for the uninfected partner reduce the risk of heterosexual HIV transmission. Several demonstration projects suggest the feasibility and acceptability of antiretroviral (ARV)s as periconception HIV-prevention for HIV-serodiscordant couples. The application of ARVs to periconception risk reduction may be limited by adherence.

SUMMARY:

For male-infected (M+F-) couples who cannot access sperm processing and female-infected (F+M-) couples unwilling to carry out insemination without intercourse, ART for the infected partner, PrEP for the uninfected partner, combined with treatment for sexually transmitted infections, sex limited to peak fertility, and medical male circumcision (for F+M couples) provide excellent, well tolerated options for reducing the risk of periconception HIV sexual transmission.

PMID:
23032734
PMCID:
PMC3695736
DOI:
10.1097/COH.0b013e328358bac9
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins Icon for PubMed Central
    Loading ...
    Support Center